Font Size

Understanding Ankylosing Spondylitis Medications (cont.)

Tumor Necrosis Factor Alpha Antagonist Medications (TNF Inhibitors) for Anklosing Spondylitis

Drugs in this class include etanercept (Enbrel), infliximab (Remicade), adalimumab (Humira), and golimumab (Simponi).

  • How TNF inhibitors work: These agents inhibit key factors responsible for inflammatory responses in the immune system. Etanercept, infliximab, adalimumab, and golimumab are tumor necrosis factor (TNF) antagonists. TNF is a naturally occurring chemical which promotes inflammation in the body. TNF antagonists block TNF and therefore decrease inflammation.
  • Who should not use these medications: People with severe heart failure, an active infection, sepsis, or active tuberculosis should not take the drug. Patients with a skin test positive for tuberculosis or a history of histoplasmosis should undergo treatment to reduce the reactivation of these infections.
  • Use: Etanercept is taken as a subcutaneous (under the skin) injection once or twice a week. Adalimumab is taken as an injection twice a month. Golimumab is taken as an injection once a month. Infliximab is taken as a two hour intravenous infusion. This may be given in a doctor's office, the hospital, or another outpatient facility. It is infused every eight weeks, after more frequent doses initially. All of the TNF inhibitors may be used alone or with methotrexate or sulfasalazine.
  • Drug or food interactions: TNF inhibitors may increase infection risk or decrease blood cell counts when used with other immune modulators or immunosuppressant drugs (for example, anticancer agents, corticosteroids). Immunization with some vaccines may not be effective.
  • Side effects: TNF inhibitors must be used with caution in people with heart failure or impaired kidney function. If a serious infection develops, the drug must be discontinued. Exacerbation of tuberculosis, infection with unusual organisms, and the rare development of drug-induced lupus are other rare but serious side effects. The following are other possible adverse effects:
    • Etanercept, adalimumab and golimumab sometimes cause injection site pain, redness, and swelling.
    • Reactions to the intravenous infusion of infliximab may occur such as shortness of breath and hives.
    • Fever
    • Rash
    • Cold or flu symptoms
    • Stomach upset
    • Nausea
    • Vomiting
Medically Reviewed by a Doctor on 6/16/2016

Must Read Articles Related to Understanding Ankylosing Spondylitis Medications

Ankylosing Spondylitis, Neurologic Perspective
Ankylosing Spondylitis, Neurologic Perspective Ankylosing spondylitis (AS) is a long-term disease that affects the joints near the center of the body, especially the spine and sacroiliac joints. Symptoms inc...learn more >>
Ankylosing Spondylitis, Orthopedic Perspective
Ankylosing Spondylitis, Orthopedic Perspective Ankylosing spondylitis (AS) is a chronic inflammation of the joints where the spine and pelvis fit together. This form of learn more >>

Patient Comments & Reviews

The eMedicineHealth doctors ask about Ankylosing Spondylitis Medications:

Ankylosing Spondylitis - Treatment

What medications and treatment did you receive for Ankylosing Spondylitis?

Read What Your Physician is Reading on Medscape

Ankylosing Spondylitis and Undifferentiated Spondyloarthropathy »

The spondyloarthropathies (SpAs) are a family of related disorders that includes ankylosing spondylitis (AS), reactive arthritis (ReA; also known as Reiter syndrome [RS]), psoriatic arthritis (PsA), spondyloarthropathy associated with inflammatory bowel disease (IBD), undifferentiated spondyloarthropathy (USpA), and, possibly, Whipple disease and Behçet disease.

Read More on Medscape Reference »

Medical Dictionary